Role of cytochrome P450 phenotyping in cancer treatment.
Dees
E Claire
EC
Watkins
Paul B
PB
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics* / Q000378:metabolism*; D000077143:Docetaxel; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010641:Phenotype; D043823:Taxoids / Q000008:administration & dosage* / Q000493:pharmacokinetics
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D003577:Cytochrome P-450 Enzyme System; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A